Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Why does multiple sclerosis only affect human primates?
Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study.
Multiple sclerosis: Oligoclonal bands-a useful tool to avoid MS misdiagnosis.
Sexuality and multiple sclerosis.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab.
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome.
Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
Development and aging of superficial white matter myelin from young adulthood to old age: Mapping by vertex-based surface statistics (VBSS).
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography.
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Neuroinflammation: no rose by any other name.
An updated role of microRNA-124 in central nervous system disorders: a review.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Demyelinating disease: Important role for KIR4.1 in demyelinating diseases.
Pages
« first
‹ previous
…
566
567
568
569
570
571
572
573
574
…
next ›
last »